A 28-year-old woman with PCOS-related anovulation is counselled about ovulation induction agents. Which feature best distinguishes clomiphene citrate from letrozole in terms of mechanism and clinical effect?

Explanation

## Mechanism Comparison: Clomiphene Citrate vs Letrozole ### Clomiphene Citrate (SERM) **Key Point:** Selective estrogen receptor modulator (SERM) that acts centrally at the hypothalamus and pituitary. 1. Blocks negative feedback of estrogen at hypothalamic–pituitary axis 2. Increases GnRH pulsatility → ↑ FSH and LH secretion 3. Results in multifollicular recruitment (not monofollicular) 4. Higher estrogen levels during cycle ### Letrozole (Aromatase Inhibitor) **Key Point:** Non-steroidal aromatase inhibitor that acts peripherally. 1. Blocks conversion of androgens → estrogens in granulosa cells 2. Reduces local and systemic estrogen levels 3. Relieves negative feedback at hypothalamus → ↑ FSH 4. More physiologic FSH rise; better follicle selection 5. Lower circulating estrogen; reduced endometrial proliferation ### Discriminating Feature | Feature | Clomiphene Citrate | Letrozole | |---------|-------------------|----------| | **Drug class** | SERM | Aromatase inhibitor | | **Site of action** | Central (hypothalamus/pituitary) | Peripheral (ovarian granulosa) | | **Mechanism of FSH ↑** | Direct central estrogen antagonism | Reduced peripheral estrogen → relief of negative feedback | | **Follicle pattern** | Multifollicular (not mono) | Monofollicular or oligofollicular | | **Endometrial thickness** | Often reduced (SERM effect) | Preserved/normal | | **Pregnancy rate** | Slightly lower in PCOS | Slightly higher in PCOS | **High-Yield:** The **central vs. peripheral** site of action is the fundamental distinction. Clomiphene acts directly at the pituitary; letrozole acts at the ovary. **Clinical Pearl:** In PCOS, letrozole is increasingly preferred because it avoids the antiestrogenic effect on the endometrium and produces more physiologic FSH secretion. **Warning:** Both agents cause multifollicular development in PCOS — the "monofollicular" myth about letrozole is misleading. Letrozole produces *fewer* follicles than clomiphene, but still multifollicular in most PCOS cases. [cite:Eshre Guideline on Ovulation Induction 2023]